Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniël M Miedema

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Pathology|April 26, 2022
Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer<sup>†</sup>Tom van den Bosch, Daniël M Miedema, Louis Vermeulen
Cancers|October 27, 2022
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor HeterogeneityTom van den Bosch, Sarah Derks, Daniël M Miedema
Molecular & Cellular Oncology|October 7, 2021
Predicting survival of cancer patients by chromosomal copy number heterogeneityTom Van Den Bosch, Erik van Dijk, Louis Vermeulen, et al.
British Journal of Cancer|July 21, 2022
Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapyTom van den Bosch, Oscar M Rueda, Carlos Caldas, et al.
Molecular & Cellular Oncology|February 22, 2019
Cancer stem cells: here, there, and everywhereSophie C Lodestijn, Kristiaan J Lenos, Daniël M Miedema, et al.
Plos One|February 14, 2020
The crowding dynamics of the motor protein kinesin-IIVandana S Kushwaha, Seyda Acar, Daniël M Miedema, et al.
Nature Protocols|August 18, 2019
A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissueKristiaan J Lenos, Sophie C Lodestijn, Scott K Lyons, et al.
Cell Reports|October 23, 2021
Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancerSophie C Lodestijn, Daniël M Miedema, Kristiaan J Lenos, et al.
JAMA Network Open|April 26, 2021
Predictors of 30-Day Mortality Among Dutch Patients Undergoing Colorectal Cancer Surgery, 2011-2016Tom van den Bosch, Anne-Loes K Warps, Michael P M de Nerée Tot Babberich, et al.
Cell Reports|November 13, 2024
Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomasKaren van der Sluis, Johanna W van Sandick, Willem J Koemans, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Pathology|April 26, 2022
Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer<sup>†</sup>Tom van den Bosch, Daniël M Miedema, Louis Vermeulen
Cancers|October 27, 2022
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor HeterogeneityTom van den Bosch, Sarah Derks, Daniël M Miedema
Molecular & Cellular Oncology|October 7, 2021
Predicting survival of cancer patients by chromosomal copy number heterogeneityTom Van Den Bosch, Erik van Dijk, Louis Vermeulen, et al.
British Journal of Cancer|July 21, 2022
Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapyTom van den Bosch, Oscar M Rueda, Carlos Caldas, et al.
Molecular & Cellular Oncology|February 22, 2019
Cancer stem cells: here, there, and everywhereSophie C Lodestijn, Kristiaan J Lenos, Daniël M Miedema, et al.
Plos One|February 14, 2020
The crowding dynamics of the motor protein kinesin-IIVandana S Kushwaha, Seyda Acar, Daniël M Miedema, et al.
Nature Protocols|August 18, 2019
A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissueKristiaan J Lenos, Sophie C Lodestijn, Scott K Lyons, et al.
Cell Reports|October 23, 2021
Marker-free lineage tracing reveals an environment-instructed clonogenic hierarchy in pancreatic cancerSophie C Lodestijn, Daniël M Miedema, Kristiaan J Lenos, et al.
JAMA Network Open|April 26, 2021
Predictors of 30-Day Mortality Among Dutch Patients Undergoing Colorectal Cancer Surgery, 2011-2016Tom van den Bosch, Anne-Loes K Warps, Michael P M de Nerée Tot Babberich, et al.
Cell Reports|November 13, 2024
Karyotype evolution in response to chemoradiotherapy and upon recurrence of esophageal adenocarcinomasKaren van der Sluis, Johanna W van Sandick, Willem J Koemans, et al.
Pageof 2